Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma

European Journal of Ophthalmology

Volumn 18, Issue 3, 2008, Pages 466-468

  Narayanan, R ^a   Shah, Vinay A ^b  

^a L V PRASAD EYE INSTITUTE   (India)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Avastin; Bevacizumab; Choroidal neovascular membrane; Choroidal osteoma; Osteoma

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; B SCAN; CASE REPORT; DRUG EFFICACY; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR PRESSURE; OPTICAL COHERENCE TOMOGRAPHY; OSTEOMA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETREATMENT; SLIT LAMP; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; TONOMETRY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 54749141966     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800327     Document Type: Article

References (11)

1. Gass JD, Guerry RK, Jack RL, Harris G. Choroidal osteoma. Arch Ophthalmol 1978; 96: 428-35.
2. Aylward GW, Chang TS, Pautler SE, Gass JD. A long-term follow-up of choroidal osteoma. Arch Ophthalmol 1998; 116:1337-41.
3. Kadrmas EF, Weiter JJ. Choroidal osteoma. Int Ophthalmol Clin 1997; 37: 171-82.
4. Morrison DL, Magargal LE, Ehrlich DR, Goldberg RE, Robb Doyle E. Review of choroidal osteoma: successful krypton red laser photocoagulation of an associated subretinal neovascular membrane involving the fovea. Ophthalmic Surg 1987; 18: 299-303.
5. Blaise P, Duchateau E, Comhaire Y, Rakic JM. Improvement of visual acuity after photodynamic therapy for choroidal neovascularization in choroidal osteoma. Acta Ophthalmol Scand 2005; 83: 515-6.
6. Shukla D, Tanawade RG, Ramasamy K. Transpupillary thermotherapy for subfoveal choroidal neovascular membrane in choroidal osteoma. Eye 2006; 20: 845-7.
7. Lazic R, Gabric N. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245: 68-73.
8. Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 2006; 19: 361-72.
9. Rosenfeld PJ, Brown DM, Heier JS, et al, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-31.
10. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006; 26: 383-90.
11. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363-72.